PrecisionLife logo web.png

PrecisionLife Ltd

Digital Health

Membership category
Emerging Y3

Unit 8B Bankside, Hanborough Business Park, Witney, OX29 8LJ, United Kingdom

PrecisionLife Ltd at a glance

Precisionlife is an AI enabled precision medicine company with a radical new approach to complex disease analysis using genomic and clinical data enabling patient stratification and novel target discovery.

About PrecisionLife Ltd

PrecisionLife is a precision medicine company founded in 2015, built on a shared vision to bring a new level of analytical capability to computational biology, genomic medicine and healthcare. They focus on finding better treatment options for individuals/people with unmet medical needs through the high-resolution stratification of patient population data. The PrecisionLife platform is hypothesis free and able to identify novel disease signatures in multi-omic patient population data. These disease signatures explain the differences in disease risk, experience and response to therapy and have applications in drug discovery, clinical trial design and real-world evidence studies. They’ve built a massively scalable analytical platform that transforms multi-omic patient population datasets (genomic, phenotypic and clinical) into disease maps. Each disease map reveals a deeper understanding of the mechanisms of complex diseases than traditional GWAS or AI/ML methods and puts high-resolution patient stratification at the heart of treatment and new medicines discovery and development. Disease maps can power applications across the healthcare value chain and they plan use multi-omic patient data to prioritise neuropsychiatric, cardiometabolic and respiratory diseases over the next 24 months, driving our commercial partnering discussions with biopharma and CROs.

Therapeutic area(s)

Articles PrecisionLife Ltd has contributed to